{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:15:59Z","timestamp":1761765359196},"reference-count":21,"publisher":"VM Media Group sp. z o.o","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Folia Histochem Cytobiol."],"DOI":"10.2478\/v10042-010-0058-3","type":"journal-article","created":{"date-parts":[[2010,11,12]],"date-time":"2010-11-12T03:05:33Z","timestamp":1289531133000},"source":"Crossref","is-referenced-by-count":18,"title":["Fas\/FasL expression in colorectal cancer. An immunohistochemical study."],"prefix":"10.5603","volume":"48","author":[{"given":"Anna","family":"Pryczynicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Guzi\u0144ska-Ustymowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Kemona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3595","published-online":{"date-parts":[[2010,11,13]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0140-6736(93)91154-E","article-title":"Apoptosis and disease","volume":"341","author":"D. Carson","year":"1993","journal-title":"Lancet"},{"key":"2","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.7533326","article-title":"The Fas death factor","volume":"267","author":"S. Nagata","year":"1995","journal-title":"Science"},{"key":"3","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/0092-8674(93)90326-L","article-title":"Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family","volume":"75","author":"T. Suda","year":"1993","journal-title":"Cell"},{"key":"4","first-page":"415","article-title":"Constitutive and induced expression of APO-1 a new member of the nerve growth fator\/tumor necrosis factor receptor superfamily, in normal and neoplastic cells","volume":"69","author":"F. Leithauser","year":"1993","journal-title":"Lab Invest"},{"key":"5","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4049\/jimmunol.157.5.1919","article-title":"Perforin, Fas ligand, and tumour necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells","volume":"157","author":"R. Lee","year":"1996","journal-title":"J Immunol"},{"key":"6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2478\/v10039-008-0015-y","article-title":"Fas expression in primary breast cancer is related to neoplastic infiltration of perilymphatic fat","volume":"53","author":"M. B\u0119benek","year":"2008","journal-title":"Adv Med Sci"},{"key":"7","first-page":"1007","article-title":"Human lung neoplasms express Fas ligand","volume":"57","author":"G. Niehans","year":"1997","journal-title":"Cancer Res"},{"key":"8","first-page":"2464","article-title":"Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer","volume":"5","author":"M. Shibakita","year":"1999","journal-title":"Clin Cancer Res"},{"key":"9","first-page":"1157","article-title":"Expression of Fas ligand in gastric carcinoma relates to lymph node metastasis","volume":"18","author":"H. Nagashima","year":"2001","journal-title":"Int J Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/jcp.39.6.585","article-title":"Lymphocytic infiltration and survival in rectal cancer","volume":"39","author":"J. Jass","year":"1986","journal-title":"J Clin Pathol"},{"key":"11","first-page":"105","volume-title":"Tumor budding in colorectal cancer","author":"K. Guzi\u0144ska-Ustymowicz","year":"2006"},{"key":"12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/ejso.2001.1223","article-title":"Fas ligand is upregulated during the colorectal adenoma-carcinoma sequence","volume":"28","author":"C. Belluco","year":"2002","journal-title":"Eur J Surg Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.3748\/wjg.v11.i39.6125","article-title":"Mechanism of counterattack of colorectal cancer cell by Fas\/Fas ligand system","volume":"11","author":"Q. Zhu","year":"2005","journal-title":"World J Gastroenterol"},{"key":"14","first-page":"3560","article-title":"Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis","volume":"6","author":"K. Okada","year":"2000","journal-title":"Clin Cancer Res"},{"key":"15","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.3748\/wjg.v11.i23.3632","article-title":"Fas ligand expression in colon cancer: a possible mechanism of tumor immune privilege","volume":"11","author":"W. Zhang","year":"2005","journal-title":"World J Gastroenterol"},{"key":"16","first-page":"5221","article-title":"Fas ligand expression is a risk factor for liver metastasis in colorectal cancer with venous invasion","volume":"23","author":"H. Yokomizo","year":"2003","journal-title":"Anticancer Res"},{"key":"17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000071208","article-title":"Fas ligand expression is correlated with metastasis in colorectal carcinoma","volume":"65","author":"T. Nozoe","year":"2003","journal-title":"Oncology"},{"key":"18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/path.1406","article-title":"Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status","volume":"201","author":"J. Michael-Robinson","year":"2003","journal-title":"J Pathol"},{"key":"19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00042737-200304000-00007","article-title":"Prognostic relevance of Fas (APO-1\/CD95) ligand in human colorectal cancer","volume":"15","author":"K. Sheehan","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.humpath.2007.06.010","article-title":"The \"Fas counterattack\" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability","volume":"39","author":"A. Houston","year":"2008","journal-title":"Hum Pathol"},{"key":"21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/(SICI)1096-9896(199811)186:3<240::AID-PATH173>3.0.CO;2-L","article-title":"Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer","volume":"186","author":"J. O'Connell","year":"1998","journal-title":"J Pathol"}],"container-title":["Folia Histochemica et Cytobiologica"],"original-title":[],"link":[{"URL":"https:\/\/journals.viamedica.pl\/folia_histochemica_cytobiologica\/article\/viewFile\/4201\/3456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T05:39:05Z","timestamp":1685857145000},"score":1,"resource":{"primary":{"URL":"http:\/\/czasopisma.viamedica.pl\/fhc\/article\/view\/4201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,13]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,11,13]]}},"URL":"https:\/\/doi.org\/10.2478\/v10042-010-0058-3","relation":{},"ISSN":["1897-5631","0239-8508"],"issn-type":[{"value":"1897-5631","type":"electronic"},{"value":"0239-8508","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,13]]}}}